Annual FCF
-$20.03 M
+$1.42 M+6.63%
31 December 2023
Summary:
Lisata Therapeutics annual free cash flow is currently -$20.03 million, with the most recent change of +$1.42 million (+6.63%) on 31 December 2023. During the last 3 years, it has fallen by -$11.19 million (-126.53%). LSTA annual FCF is now -2094.82% below its all-time high of $1.00 million, reached on 01 December 2002.LSTA Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$2.52 M
+$2.77 M+52.34%
30 September 2024
Summary:
Lisata Therapeutics quarterly free cash flow is currently -$2.52 million, with the most recent change of +$2.77 million (+52.34%) on 30 September 2024. Over the past year, it has increased by +$1.06 million (+29.72%). LSTA quarterly FCF is now -156.07% below its all-time high of $4.49 million, reached on 01 June 2020.LSTA Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$18.90 M
+$1.06 M+5.34%
30 September 2024
Summary:
Lisata Therapeutics TTM free cash flow is currently -$18.90 million, with the most recent change of +$1.06 million (+5.34%) on 30 September 2024. Over the past year, it has increased by +$3.56 million (+15.85%). LSTA TTM FCF is now -870.74% below its all-time high of $2.45 million, reached on 01 March 2003.LSTA TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LSTA Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +6.6% | +29.7% | +15.8% |
| 3 y3 years | -126.5% | +50.0% | +18.8% |
| 5 y5 years | +0.4% | +43.5% | -6.7% |
LSTA Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -126.5% | +10.2% | at high | +69.3% | -0.2% | +21.3% |
| 5 y | 5 years | -126.5% | +10.2% | -156.1% | +69.3% | -152.3% | +21.3% |
| alltime | all time | -2094.8% | +60.4% | -156.1% | +82.7% | -870.7% | +64.1% |
Lisata Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$2.52 M(-52.3%) | -$18.90 M(-5.3%) |
| June 2024 | - | -$5.28 M(-24.8%) | -$19.96 M(+5.8%) |
| Mar 2024 | - | -$7.03 M(+72.7%) | -$18.86 M(-5.8%) |
| Dec 2023 | -$20.03 M(-6.6%) | -$4.07 M(+13.6%) | -$20.03 M(-10.8%) |
| Sept 2023 | - | -$3.58 M(-14.4%) | -$22.46 M(-1.9%) |
| June 2023 | - | -$4.18 M(-49.0%) | -$22.90 M(-4.6%) |
| Mar 2023 | - | -$8.20 M(+26.2%) | -$24.01 M(+11.9%) |
| Dec 2022 | -$21.45 M(-3.8%) | -$6.49 M(+61.5%) | -$21.45 M(+9.7%) |
| Sept 2022 | - | -$4.02 M(-24.1%) | -$19.57 M(-4.9%) |
| June 2022 | - | -$5.30 M(-6.1%) | -$20.58 M(+3.1%) |
| Mar 2022 | - | -$5.64 M(+22.5%) | -$19.97 M(-10.5%) |
| Dec 2021 | -$22.30 M(+152.2%) | - | - |
| Dec 2021 | - | -$4.60 M(-8.6%) | -$22.30 M(-4.2%) |
| Sept 2021 | - | -$5.04 M(+7.5%) | -$23.27 M(+7.0%) |
| June 2021 | - | -$4.69 M(-41.2%) | -$21.75 M(+73.0%) |
| Mar 2021 | - | -$7.97 M(+43.1%) | -$12.57 M(+42.2%) |
| Dec 2020 | -$8.84 M(-53.2%) | -$5.57 M(+58.4%) | -$8.84 M(+18.1%) |
| Sept 2020 | - | -$3.52 M(-178.3%) | -$7.49 M(-11.1%) |
| June 2020 | - | $4.49 M(-205.8%) | -$8.43 M(-52.2%) |
| Mar 2020 | - | -$4.24 M(+0.5%) | -$17.64 M(-6.6%) |
| Dec 2019 | -$18.88 M(-6.2%) | -$4.22 M(-5.3%) | -$18.88 M(+6.7%) |
| Sept 2019 | - | -$4.46 M(-5.6%) | -$17.70 M(-2.3%) |
| June 2019 | - | -$4.72 M(-14.0%) | -$18.13 M(-6.1%) |
| Mar 2019 | - | -$5.49 M(+80.3%) | -$19.30 M(-4.1%) |
| Dec 2018 | -$20.12 M(-4.2%) | -$3.04 M(-37.7%) | -$20.12 M(-4.5%) |
| Sept 2018 | - | -$4.88 M(-17.1%) | -$21.06 M(-6.5%) |
| June 2018 | - | -$5.89 M(-6.7%) | -$22.53 M(+31.3%) |
| Mar 2018 | - | -$6.31 M(+58.2%) | -$17.16 M(-18.3%) |
| Dec 2017 | -$21.01 M(-15.2%) | -$3.99 M(-37.2%) | -$21.01 M(+2.8%) |
| Sept 2017 | - | -$6.35 M(+1131.1%) | -$20.43 M(+3.2%) |
| June 2017 | - | -$515.90 K(-94.9%) | -$19.80 M(-23.4%) |
| Mar 2017 | - | -$10.16 M(+198.2%) | -$25.85 M(+4.4%) |
| Dec 2016 | -$24.77 M(-41.6%) | -$3.41 M(-40.4%) | -$24.77 M(-19.3%) |
| Sept 2016 | - | -$5.72 M(-13.0%) | -$30.70 M(-10.9%) |
| June 2016 | - | -$6.57 M(-27.6%) | -$34.46 M(-6.7%) |
| Mar 2016 | - | -$9.07 M(-2.9%) | -$36.93 M(-13.0%) |
| Dec 2015 | -$42.44 M(-16.0%) | -$9.34 M(-1.4%) | -$42.44 M(-5.1%) |
| Sept 2015 | - | -$9.47 M(+4.8%) | -$44.74 M(-9.1%) |
| June 2015 | - | -$9.04 M(-38.0%) | -$49.24 M(-6.5%) |
| Mar 2015 | - | -$14.58 M(+25.3%) | -$52.64 M(+4.1%) |
| Dec 2014 | -$50.55 M(+69.7%) | -$11.64 M(-16.7%) | -$50.55 M(+5.3%) |
| Sept 2014 | - | -$13.97 M(+12.2%) | -$48.02 M(+16.2%) |
| June 2014 | - | -$12.45 M(-0.3%) | -$41.34 M(+17.8%) |
| Mar 2014 | - | -$12.49 M(+37.2%) | -$35.10 M(+17.8%) |
| Dec 2013 | -$29.79 M(+107.1%) | -$9.11 M(+24.9%) | -$29.79 M(-2.8%) |
| Sept 2013 | - | -$7.29 M(+17.5%) | -$30.64 M(+14.6%) |
| June 2013 | - | -$6.21 M(-13.7%) | -$26.75 M(+13.6%) |
| Mar 2013 | - | -$7.19 M(-27.8%) | -$23.55 M(+63.7%) |
| Dec 2012 | -$14.38 M(-33.1%) | -$9.96 M(+193.2%) | -$14.38 M(+82.1%) |
| Sept 2012 | - | -$3.40 M(+13.1%) | -$7.90 M(-11.0%) |
| June 2012 | - | -$3.00 M(-252.1%) | -$8.88 M(+2.9%) |
| Mar 2012 | - | $1.97 M(-156.8%) | -$8.63 M(-59.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2011 | -$21.50 M(-13.5%) | -$3.47 M(-20.6%) | -$21.50 M(-20.9%) |
| Sept 2011 | - | -$4.38 M(+59.1%) | -$27.20 M(+3.0%) |
| June 2011 | - | -$2.75 M(-74.8%) | -$26.41 M(-10.2%) |
| Mar 2011 | - | -$10.90 M(+18.9%) | -$29.41 M(+18.3%) |
| Dec 2010 | -$24.85 M(+131.0%) | -$9.17 M(+155.5%) | -$24.85 M(+53.0%) |
| Sept 2010 | - | -$3.59 M(-37.6%) | -$16.24 M(-7.5%) |
| June 2010 | - | -$5.75 M(-9.4%) | -$17.56 M(+10.8%) |
| Mar 2010 | - | -$6.35 M(+1040.2%) | -$15.85 M(+47.3%) |
| Dec 2009 | -$10.76 M(+126.9%) | -$556.60 K(-88.6%) | -$10.76 M(-4.9%) |
| Sept 2009 | - | -$4.90 M(+21.2%) | -$11.32 M(+54.1%) |
| June 2009 | - | -$4.04 M(+221.2%) | -$7.34 M(+59.8%) |
| Mar 2009 | - | -$1.26 M(+12.7%) | -$4.60 M(-3.1%) |
| Dec 2008 | -$4.74 M(-24.1%) | -$1.12 M(+20.7%) | -$4.74 M(-9.9%) |
| Sept 2008 | - | -$925.00 K(-28.6%) | -$5.26 M(-16.6%) |
| June 2008 | - | -$1.30 M(-7.7%) | -$6.31 M(+6.1%) |
| Mar 2008 | - | -$1.40 M(-14.1%) | -$5.94 M(-4.9%) |
| Dec 2007 | -$6.25 M(+69.8%) | -$1.64 M(-17.1%) | -$6.25 M(+15.4%) |
| Sept 2007 | - | -$1.97 M(+111.6%) | -$5.42 M(+19.3%) |
| June 2007 | - | -$932.00 K(-45.5%) | -$4.54 M(-0.5%) |
| Mar 2007 | - | -$1.71 M(+113.6%) | -$4.57 M(+24.0%) |
| Dec 2006 | -$3.68 M(+341.5%) | -$801.20 K(-27.0%) | -$3.68 M(+13.7%) |
| Sept 2006 | - | -$1.10 M(+14.8%) | -$3.24 M(+41.7%) |
| June 2006 | - | -$955.90 K(+15.5%) | -$2.29 M(+45.8%) |
| Mar 2006 | - | -$827.70 K(+132.2%) | -$1.57 M(+87.9%) |
| Dec 2005 | -$834.00 K(-43.0%) | -$356.50 K(+146.0%) | -$834.00 K(+2.2%) |
| Sept 2005 | - | -$144.90 K(-39.1%) | -$816.40 K(-20.5%) |
| June 2005 | - | -$238.10 K(+152.0%) | -$1.03 M(-11.5%) |
| Mar 2005 | - | -$94.50 K(-72.1%) | -$1.16 M(-20.7%) |
| Dec 2004 | -$1.46 M(+42.8%) | -$338.90 K(-4.7%) | -$1.46 M(+13.9%) |
| Sept 2004 | - | -$355.60 K(-4.2%) | -$1.28 M(-20.4%) |
| June 2004 | - | -$371.10 K(-6.6%) | -$1.61 M(+18.5%) |
| Mar 2004 | - | -$397.30 K(+147.4%) | -$1.36 M(+33.0%) |
| Dec 2003 | -$1.02 M(-202.0%) | -$160.60 K(-76.6%) | -$1.02 M(-266.9%) |
| Sept 2003 | - | -$685.40 K(+476.9%) | $614.00 K(-48.5%) |
| June 2003 | - | -$118.80 K(+99.0%) | $1.19 M(-51.4%) |
| Mar 2003 | - | -$59.70 K(-104.0%) | $2.45 M(+144.2%) |
| Dec 2002 | $1.00 M(-362.3%) | $1.48 M(-1478.6%) | $1.00 M(+946.0%) |
| Sept 2002 | - | -$107.20 K(-109.4%) | $96.00 K(-179.5%) |
| June 2002 | - | $1.14 M(-175.7%) | -$120.70 K(-92.0%) |
| Mar 2002 | - | -$1.51 M(-364.6%) | -$1.52 M(+306.0%) |
| Dec 2001 | -$382.90 K(-83.7%) | $569.70 K(-275.9%) | -$373.90 K(-73.7%) |
| Sept 2001 | - | -$323.90 K(+26.3%) | -$1.42 M(-21.9%) |
| June 2001 | - | -$256.50 K(-29.4%) | -$1.82 M(-12.0%) |
| Mar 2001 | - | -$363.20 K(-24.4%) | -$2.07 M(-12.0%) |
| Dec 2000 | -$2.35 M(-25.0%) | -$480.50 K(-33.5%) | -$2.35 M(+25.7%) |
| Sept 2000 | - | -$722.30 K(+43.1%) | -$1.87 M(+62.8%) |
| June 2000 | - | -$504.80 K(-21.7%) | -$1.15 M(+78.3%) |
| Mar 2000 | - | -$644.80 K | -$644.80 K |
| Dec 1999 | -$3.13 M(+798.5%) | - | - |
| Dec 1998 | -$348.90 K(+29.4%) | - | - |
| Mar 1998 | -$269.60 K(-11.4%) | - | - |
| Mar 1997 | -$304.30 K(-64.1%) | - | - |
| Mar 1996 | -$847.40 K | - | - |
FAQ
- What is Lisata Therapeutics annual free cash flow?
- What is the all time high annual FCF for Lisata Therapeutics?
- What is Lisata Therapeutics annual FCF year-on-year change?
- What is Lisata Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Lisata Therapeutics?
- What is Lisata Therapeutics quarterly FCF year-on-year change?
- What is Lisata Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Lisata Therapeutics?
- What is Lisata Therapeutics TTM FCF year-on-year change?
What is Lisata Therapeutics annual free cash flow?
The current annual FCF of LSTA is -$20.03 M
What is the all time high annual FCF for Lisata Therapeutics?
Lisata Therapeutics all-time high annual free cash flow is $1.00 M
What is Lisata Therapeutics annual FCF year-on-year change?
Over the past year, LSTA annual free cash flow has changed by +$1.42 M (+6.63%)
What is Lisata Therapeutics quarterly free cash flow?
The current quarterly FCF of LSTA is -$2.52 M
What is the all time high quarterly FCF for Lisata Therapeutics?
Lisata Therapeutics all-time high quarterly free cash flow is $4.49 M
What is Lisata Therapeutics quarterly FCF year-on-year change?
Over the past year, LSTA quarterly free cash flow has changed by +$1.06 M (+29.72%)
What is Lisata Therapeutics TTM free cash flow?
The current TTM FCF of LSTA is -$18.90 M
What is the all time high TTM FCF for Lisata Therapeutics?
Lisata Therapeutics all-time high TTM free cash flow is $2.45 M
What is Lisata Therapeutics TTM FCF year-on-year change?
Over the past year, LSTA TTM free cash flow has changed by +$3.56 M (+15.85%)